Stocks 27th Feb '25 Number of Patients on GLP-1 Number of patients on GLP-1, whether for diabetes or obesity, has tripled in the last three years thanks to Novo Nordisk and Eli Lilly. Click to share on Twitter (Opens in new window)Click to email a link to a friend (Opens in new window)Click to share on LinkedIn (Opens in new window)
